PLCL1 anticorps (N-Term)

N° du produit ABIN5538237

Détail du produit anti-PLCL1 anticorps

Antigène: PLCL1 (phospholipase C-Like 1 (PLCL1))

Épitope: AA 149-176, N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLCL1 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This PLCL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 149-176 amino acids from the N-terminal region of human PLCL1.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

For FACS starting dilution is: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur PLCL1

Antigène: PLCL1 (phospholipase C-Like 1 (PLCL1))

Autre désignation: PLCL1 (PLCL1 Produits)

Synonymes: anticorps PLCE, anticorps PLCL, anticorps PLDL1, anticorps PRIP, anticorps C230017K02Rik, anticorps PLC-L, anticorps PLC-L1, anticorps PRIP-1, anticorps phospholipase C like 1 (inactive), anticorps phospholipase C-like 1, anticorps PLCL1, anticorps Plcl1

Sujet: PLCL1 is an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and sphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity). Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as a nhibitor of PPP1C.

Poids moléculaire: 123 kDa

ID gène: 5334

UniProt: Q15111